VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 147 filers reported holding VIKING THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $270,108 | +25.3% | 24,400 | +83.5% | 0.00% | – |
| Q2 2023 | $215,593 | -92.4% | 13,300 | -92.2% | 0.00% | -100.0% |
| Q1 2023 | $2,839,508 | +182.4% | 170,541 | +59.5% | 0.01% | +100.0% |
| Q4 2022 | $1,005,349 | +1029.6% | 106,952 | +226.3% | 0.00% | – |
| Q3 2022 | $89,000 | -23.3% | 32,777 | +63.9% | 0.00% | -100.0% |
| Q3 2020 | $116,000 | -37.3% | 20,000 | -22.1% | 0.00% | 0.0% |
| Q2 2020 | $185,000 | +270.0% | 25,669 | +139.9% | 0.00% | – |
| Q1 2020 | $50,000 | -96.5% | 10,700 | -94.0% | 0.00% | -100.0% |
| Q4 2019 | $1,427,000 | +94.4% | 178,000 | +101.4% | 0.01% | +66.7% |
| Q2 2019 | $734,000 | -61.8% | 88,400 | -54.3% | 0.01% | -60.0% |
| Q1 2019 | $1,923,000 | +63.0% | 193,500 | +25.4% | 0.02% | +87.5% |
| Q4 2018 | $1,180,000 | +164.6% | 154,303 | +502.8% | 0.01% | +300.0% |
| Q3 2018 | $446,000 | +30.4% | 25,598 | -28.9% | 0.00% | 0.0% |
| Q2 2018 | $342,000 | -58.2% | 35,987 | -80.8% | 0.00% | -60.0% |
| Q1 2018 | $818,000 | – | 187,096 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |